XML 35 R25.htm IDEA: XBRL DOCUMENT v3.23.3
Stock-Based Compensation (Tables)
 9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-Based Compensation
Compensation costs that have been included in our condensed consolidated statements of operations and comprehensive loss for all stock-based compensation arrangements is set forth below:
Three Months Ended September 30,Nine Months Ended September 30,
Stock-based compensation2023202220232022
Cost of revenues$80 $59 $444 $154 
Sales and marketing24 35 156 80 
General and administrative699 760 2,818 1,827 
Research and development35 45 244 108 
Total stock-based compensation$838 $899 $3,662 $2,169 
Schedule of Restricted Stock Unit Activity A summary of our restricted stock unit activity under the 2018 Plan for the nine months ended September 30, 2023 is set forth below:
SharesWeighted Average Grant Date Fair Value
Outstanding as of December 31, 20222,957,995 $1.75 
Granted6,211,386 0.53 
Released(3,215,131)1.19 
Forfeited(578,574)1.43 
Outstanding as of September 30, 20235,375,676 $0.62 
Schedule of Stock Option Activity
A summary of our stock option activity under the 2018 Plan and related information is as follows:
Number of SharesWeighted Average
Exercise Price		Weighted Average
Remaining
Contractual Term
(years)		Aggregate Intrinsic
Value
Outstanding as of December 31, 202287,500 $1.43 5.6$— 
Granted75,000 0.76 
Exercised— — 
Forfeited(37,500)1.08 
Outstanding as of September 30, 2023125,000 $1.14 5.4$— 
Exercisable as of September 30, 2023106,250 $1.20 5.4$— 
A summary of our option activity under the 2009 Plan and related information is as follows:
Number of SharesWeighted Average
Exercise Price		Weighted Average
Remaining
Contractual Term
(years)		Aggregate Intrinsic
Value
Outstanding as of December 31, 2022874,279 $0.80 4.2$130 
Granted— — 
Exercised(94,748)0.61 
Forfeited(24,021)1.31 
Outstanding as of September 30, 2023755,510 $0.81 4.0$— 
Exercisable as of September 30, 2023755,510 $0.81 4.0$—